Octreotide Acetate
NDC 67457-246, octreotide acetate, injection, solution, from Mylan Institutional LLC.
- Product NDC
- 67457-246
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA079198
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-246 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTREOTIDE ACETATE500 ug/mL
Pharmacologic classes
Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-246-01 | 67457024601 | 10 SYRINGE in 1 CARTON (67457-246-01) / 1 mL in 1 SYRINGE (67457-246-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2d78d5d1-77b2-4da1-98d4-d9c36e743ce2Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67457-246
Use it
Look up 67457-246 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-246 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-246. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.